These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28399250)

  • 21. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of resistance to antimicrobial agents of H. pylori].
    Raymond J; Kalach N; Lamarque D; Burucoa C
    Arch Pediatr; 2010 Jun; 17(6):816-7. PubMed ID: 20654908
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
    Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
    Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
    Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
    Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment strategies for Helicobacter pylori infection.
    Damianos AJ; McGarrity TJ
    Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mono and dual therapy for Helicobacter pylori associated gastritis.
    Gill HH; Desai HG; Mehta PR; Ranganathan S; Kalro RH; Murti PK; Prabhu SR
    J Assoc Physicians India; 1991 Oct; 39(10):743-5. PubMed ID: 1816196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in peptic ulcer disease: Helicobacter pylori infection and its treatment.
    Podolski JL
    Gastroenterol Nurs; 1996; 19(4):128-36. PubMed ID: 8852158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
    Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quadruple therapy is more effective against H. pylori].
    Oberhofer E
    MMW Fortschr Med; 2016 May; 158(9):20. PubMed ID: 27155683
    [No Abstract]   [Full Text] [Related]  

  • 34. [How to diagnose functional (non-ulcerative) dyspepsia (review)].
    Maev IV; B'iuchnova ES; Lebedeva EG; Iakimova SS
    Ter Arkh; 2004; 76(11):57-60. PubMed ID: 15658539
    [No Abstract]   [Full Text] [Related]  

  • 35. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 36. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
    Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
    Engstrand L; Graham D; Scheynius A; Genta RM; El-Zaatari F
    Am J Clin Pathol; 1997 Nov; 108(5):504-9. PubMed ID: 9353088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori: a human pathogen.
    Murray L; Harvey I
    Lancet; 1995 Jun; 345(8964):1579-80. PubMed ID: 7791471
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.